244 related articles for article (PubMed ID: 16596311)
1. The anti-tumor activity of pineal melatonin and cancer enhancing life styles in industrialized societies.
Bartsch C; Bartsch H
Cancer Causes Control; 2006 May; 17(4):559-71. PubMed ID: 16596311
[TBL] [Abstract][Full Text] [Related]
2. Circadian disruption, shift work and the risk of cancer: a summary of the evidence and studies in Seattle.
Davis S; Mirick DK
Cancer Causes Control; 2006 May; 17(4):539-45. PubMed ID: 16596308
[TBL] [Abstract][Full Text] [Related]
3. Circadian stage-dependent inhibition of human breast cancer metabolism and growth by the nocturnal melatonin signal: consequences of its disruption by light at night in rats and women.
Blask DE; Dauchy RT; Brainard GC; Hanifin JP
Integr Cancer Ther; 2009 Dec; 8(4):347-53. PubMed ID: 20042410
[TBL] [Abstract][Full Text] [Related]
4. Artificial lighting in the industrialized world: circadian disruption and breast cancer.
Stevens RG
Cancer Causes Control; 2006 May; 17(4):501-7. PubMed ID: 16596303
[TBL] [Abstract][Full Text] [Related]
5. Lighting for the human circadian clock: recent research indicates that lighting has become a public health issue.
Pauley SM
Med Hypotheses; 2004; 63(4):588-96. PubMed ID: 15325001
[TBL] [Abstract][Full Text] [Related]
6. Melatonin, sleep disturbance and cancer risk.
Blask DE
Sleep Med Rev; 2009 Aug; 13(4):257-64. PubMed ID: 19095474
[TBL] [Abstract][Full Text] [Related]
7. Light during darkness and cancer: relationships in circadian photoreception and tumor biology.
Jasser SA; Blask DE; Brainard GC
Cancer Causes Control; 2006 May; 17(4):515-23. PubMed ID: 16596305
[TBL] [Abstract][Full Text] [Related]
8. Melatonin, environmental light, and breast cancer.
Srinivasan V; Spence DW; Pandi-Perumal SR; Trakht I; Esquifino AI; Cardinali DP; Maestroni GJ
Breast Cancer Res Treat; 2008 Apr; 108(3):339-50. PubMed ID: 17541739
[TBL] [Abstract][Full Text] [Related]
9. Risk of breast cancer after night- and shift work: current evidence and ongoing studies in Denmark.
Hansen J
Cancer Causes Control; 2006 May; 17(4):531-7. PubMed ID: 16596307
[TBL] [Abstract][Full Text] [Related]
10. Melatonin as a biomarker of circadian dysregulation.
Mirick DK; Davis S
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3306-13. PubMed ID: 19064543
[TBL] [Abstract][Full Text] [Related]
11. [Shift and night work--is it a cancer risk factor?].
Bilski B
Med Pr; 2005; 56(2):175-8. PubMed ID: 20067218
[TBL] [Abstract][Full Text] [Related]
12. A generalized theory of carcinogenesis due to chronodisruption.
Erren TC; Reiter RJ
Neuro Endocrinol Lett; 2008 Dec; 29(6):815-21. PubMed ID: 19112419
[TBL] [Abstract][Full Text] [Related]
13. Is light-at-night a health risk factor or a health risk predictor?
Kantermann T; Roenneberg T
Chronobiol Int; 2009 Aug; 26(6):1069-74. PubMed ID: 19731106
[TBL] [Abstract][Full Text] [Related]
14. The pineal gland and cancer.
Ronco AL; Halberg F
Anticancer Res; 1996; 16(4A):2033-9. PubMed ID: 8712739
[TBL] [Abstract][Full Text] [Related]
15. Melatonin and human rhythms.
Arendt J
Chronobiol Int; 2006; 23(1-2):21-37. PubMed ID: 16687277
[TBL] [Abstract][Full Text] [Related]
16. Effects of exogenous melatonin and circadian synchronization on tumor progression in melanoma-bearing C57BL6 mice.
Otálora BB; Madrid JA; Alvarez N; Vicente V; Rol MA
J Pineal Res; 2008 Apr; 44(3):307-15. PubMed ID: 18339126
[TBL] [Abstract][Full Text] [Related]
17. Role of circadian rhythm and endogenous melatonin in pathogenesis of acute gastric bleeding erosions induced by stress.
Brzozowski T; Zwirska-Korczala K; Konturek PC; Konturek SJ; Sliwowski Z; Pawlik M; Kwiecien S; Drozdowicz D; Mazurkiewicz-Janik M; Bielanski W; Pawlik WW
J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():53-64. PubMed ID: 18212400
[TBL] [Abstract][Full Text] [Related]
18. Work at night and breast cancer--report on evidence-based options for preventive actions.
Bonde JP; Hansen J; Kolstad HA; Mikkelsen S; Olsen JH; Blask DE; Härmä M; Kjuus H; de Koning HJ; Olsen J; Møller M; Schernhammer ES; Stevens RG; Åkerstedt T
Scand J Work Environ Health; 2012 Jul; 38(4):380-90. PubMed ID: 22349009
[TBL] [Abstract][Full Text] [Related]
19. [Light-dark conditions, melatonin and risk of cancer].
Anisimov VN; Vinogradova IA
Vopr Onkol; 2006; 52(5):491-8. PubMed ID: 17168354
[No Abstract] [Full Text] [Related]
20. Melatonin and mammary pathological growth.
Cos S; Sánchez-Barceló EJ
Front Neuroendocrinol; 2000 Apr; 21(2):133-70. PubMed ID: 10764528
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
